Cyclo (leucylglycine) inhibits the development of morphine induced analgesic tolerance and dopamine receptor supersensitivity in rats.
D000698:Analgesia; D000818:Animals; D004151:Dipeptides / Q000494:pharmacology*; D004361:Drug Tolerance; D006207:Half-Life; D006801:Humans; D008297:Male; D009020:Morphine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009479:Neuropeptides; D010456:Peptides, Cyclic; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D013375:Substance Withdrawal Syndrome / Q000523:psychology
D004151:Dipeptides; D009479:Neuropeptides; D010456:Peptides, Cyclic; D011954:Receptors, Dopamine; C021166:cyclo(leucylglycine); D009020:Morphine